Orphan drugs have been a hot topic of late. We created this card which shows a steady increase in the number of companies receiving orphan drug designations from the FDA.
Be the first to start the conversation!
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.
karmadata is a collaborative information service. We are creating a new platform for consumers of information to create and share data, visualizations, and knowledge on the web. We believe in individual users, not corporate subscriptions.